XML 37 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2022
Summary of Time-Based RSUs Activity

Weighted average

Number

grant date

of shares

fair value

Outstanding at December 31, 2021

7,392

$

19.78

Granted

3,650

11.36

Vested

(1,845)

14.69

Forfeited

(322)

22.50

Outstanding at March 31, 2022

8,875

$

17.28

Schedule of Stock-Based Compensation Expense

Three Months Ended March 31,

2022

2021

Cost of revenue

$

1,758

$

992

Research and development

8,965

3,048

Sales, general and administrative

11,980

6,125

Total stock-based compensation expense

$

22,703

$

10,165

Schedule of Fair Value of Employee Stock Purchase Plan

Three Months Ended March 31,

2022

2021

Expected term in years

0.5 - 2.0

0.5 - 2.0

Expected volatility

70%

68%

Risk-free interest rate

0.60% - 1.31%

0.07% - 0.13%

Dividend yield

—  

Weighted average grant date fair value per share

$

5.42

$

29.26

Time-based stock options [Member]  
Summary of Stock Option Activity

Stock Options Outstanding

Weighted

Number

average

of shares

Exercise price

exercise price

Outstanding at December 31, 2021

12,159

$

1.1646.37

$

11.38

Granted

3,798

10.1816.58

11.76

Exercised

(178)

1.168.90

3.38

Canceled

(232)

2.4746.37

27.74

Outstanding at March 31, 2022

15,547

$

1.1646.37

$

11.32

Performance-based stock options [Member]  
Summary of Stock Option Activity

Stock Options Outstanding

Weighted

Number

average

of shares

Exercise price

exercise price

Outstanding at December 31, 2021

304

$

4.71 - 4.90

$

4.71

Granted

Exercised

Canceled

Outstanding at March 31, 2022

304

$

4.71 - 4.90

$

4.71